Determining brain death after therapeutic hypothermia on nonpulsatile continuous-flow mechanical circulatory support devices.
نویسندگان
چکیده
Goswami et al1 described 2 cases of determining brain death (BD) after therapeutic hypothermia (TH) in patients supported on nonpulsatile continuous-flow (NPCF) systemic circulation and extracorporal membrane oxygenation. We comment on TH, sedatives, and NPCF as confounders for reversible inhibition of the central nervous system (CNS) and BD findings. Goswami et al1 performed BD examination at 24 to 48 hours after discontinuing TH and sedatives. TH has unpredictable effects on the pharmacokinetics and pharmacodynamics of drugs acting on the central -aminobutyric acid (GABA) reeptors (eg, benzodiazepines, barbiturates, propofol, and aclofen). These drugs potentiate the GABA inhibitory effects n neurotransmission and depress the CNS-producing reversble neurologic findings. Reversible BD findings have been eported several days after discontinuing TH and sedatives.2-4 Brainstem reflexes returned 96 hours after discontinuing propofol, which could not be predicted from the kinetics of drug clearance.4 Baclofen induced a brain-death-like syndrome that as reversed after 5 to 7 days, which exceeded the recomended waiting time of 5 times the drug’s half-life.5 Plasma learance of the drug might not exclude persistent inhibitory ABA action on the CNS because the drug concentration in rain tissue is not routinely measured. Goswami et al1 performed 2 BD examinations at a 6-hour nterval.1 The optimal timing of the second BD examination after TH is unknown. Joffe et al2 reviewed 12 cases of adult and ediatric cases with BD findings that reversed between 12 ours to several days after the first BD examination.2 Confounding factors were not recognized before the first BD examination (eg, sedatives and TH) and could explain reversible brain death findings in these cases.2,4,6,7 Delaying the second BD examination for several days could eliminate the residual pharmacologic CNS inhibition and reversibility of neurologic findings.2-4 Goswami et al1 reduced the sweep gas flow on extracorporal membrane oxygenation raising acutely the arterial carbon dioxide concentration.1 Inducing acute arterial hypercapnia can have detrimental effects on cerebral perfusion and worsen pre-existing acute neurologic injuries.8,9 Performing the apnea est soon after rewarming to normothermia can result in a alse-positive test and abolish any favorable neurologic outome of TH. Furthermore, the hypercapnic hyperoxic apnea est does not verify irreversible cessation of the medullary espiratory rhythm centers.8 Goswami et al1 determined BD according to the 2010 American Academy of Neurology (AAN) guideline.1 The authors claimed that BD determination complied with the Uniform Determination of Death Act of “irreversible cessation of all functions of the whole brain and the brainstem.”1 However, the AAN assigned the evidence level “U” (ie, insufficient or conflicting data) to several critical elements in BD determination.10 2
منابع مشابه
Factors influencing the rate of flow through continuous-flow left ventricular assist devices at rest and with exercise.
T he heart failure (HF) community has witnessed a rapid evolution in mechanical circulatory support over the past decade. Following publication of the pivotal HeartMate II trials, continuous-flow left ventricular assist devices (cfLVADs) with an axial rotor (e.g., HeartMate II) quickly replaced the first-generation, pulsatile devices as both a bridge to transplant and as destination therapy for...
متن کاملAdvances in Mechanical Circulatory Support Imaging for Ventricular Function and Myocardial Recovery on Nonpulsatile Ventricular Assist Devices
Advances in the field of device support have led to increased use of continuous-flow left ventricular assist devices (LVADs) to improve outcomes in patients with end-stage heart disease. Newer-generation LVADs have become the pump of choice for bridging to heart transplantation and as destination therapy for patients with contraindications to transplantation.1 Different imaging modalities have ...
متن کاملCoagulation and complications of left ventricular assist device therapy: a primer for emergency nurses.
Implantation of left ventricular assist devices (LVADs) is becoming more common with the advancement of mechanical circulatory support technology and the continued insufficient number of organ donors available for heart transplantation. Modern LVADs provide a mechanically induced, nonpulsatile, continuous blood flow that drastically alters the hemodynamic and coagulation profile of patients usi...
متن کاملPediatric ventricular assist devices: current challenges and future prospects
The field of mechanical circulatory support has made great strides in the preceding 2 decades. Although pediatric mechanical circulatory support has lagged behind that of adults, the gap between them is expected to close soon. The only device currently approved by the US Food and Drug Administration for use in children is the Berlin Heart EXCOR ventricular assist device (VAD). The prospective B...
متن کاملFirst clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation.
BACKGROUND A shortage of donor organs and increased numbers of deaths of patients on the waiting list for cardiac transplantation make mechanical circulatory support for a bridge to transplantation a standard clinical procedure. Continuous-flow rotary blood pumps offer exciting new perspectives. METHODS AND RESULTS Two male patients (ages 44 and 65 years) suffering from end-stage left heart f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of cardiothoracic and vascular anesthesia
دوره 27 2 شماره
صفحات -
تاریخ انتشار 2013